Key result
Integrating Traditional Chinese and Western medicine improves angina and coronary flow reserve in CMVD.
Why the study?
Coronary microvascular disease is common and increases cardiovascular risk, but effective modern medical treatments are lacking and research gaps remain.
Does Traditional Chinese medicine improve outcomes in patients with coronary microvascular disease?
Does Traditional Chinese medicine improve outcomes in patients with coronary microvascular disease?
Answers are grounded in this paper and cite their sources.
This review highlights the potential clinical efficacy and mechanisms of Traditional Chinese Medicine for treating coronary microvascular disease, an area currently lacking effective modern medical treatments.
Coronary microvascular disease (CMVD) is common in patients with cardiovascular risk factors and is associated with an increased risk of adverse cardiovascular events. Although the study of CMVD in modern medicine is ongoing, there is still no effective treatment for it. Traditional Chinese medicine (TCM) has some clinical advantages based on syndrome differentiation and individualized treatment. In this review, we review the clinical significance, pathogenesis, and current treatments of CMVD and systematically summarize the clinical efficacy and potential action mechanisms of TCM for CMVD. In addition, the scientific problems that need to be solved urgently and the research strategy of TCM for CMVD are described. CMVD has great clinical significance, but there are still many gaps in the related research. This review aims to attract the attention of clinicians to CMVD and promote research on CMVD in TCM.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2022) conducted a review in Coronary microvascular disease (CMVD). Traditional Chinese Medicine (TCM) vs. Western medicine was evaluated. Integrated Traditional Chinese and Western medicine therapies were more effective than Western medicine alone in improving angina symptoms, electrocardiography, and coronary flow reserve in patients with coronary microvascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: